Item 2.02. Results of Operations and Financial Condition

On May 8, 2008, SciClone Pharmaceuticals, Inc. (the "Company") issued a press release announcing its financial results for the first quarter ended March 31, 2008. A copy of the Company's press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits

(a) Financial statements:
            None
(b) Pro forma financial information:
            None
(c) Shell company transactions:
            None
(d) Exhibits

            99.1       Press Release of SciClone Pharmaceuticals, Inc. dated May 08, 2008

SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: May 08, 2008
 SCICLONE PHARMACEUTICALS, INC.

By:  /s/ Friedhelm Blobel, Ph.D.                    
     Friedhelm Blobel, Ph.D.
     President and Chief Executive Officer

Exhibit Index
Exhibit No. Description
99.1 Press Release of SciClone Pharmaceuticals, Inc. dated May 08, 2008